Patent
Multispecific peptides
| العنوان: | Multispecific peptides |
|---|---|
| Patent Number: | 8,685,890 |
| تاريخ النشر: | April 01, 2014 |
| Appl. No: | 13/147289 |
| Application Filed: | February 04, 2010 |
| مستخلص: | The invention relates to a method for providing a multispecific peptide ligand comprising a polypeptide covalently linked to a molecular scaffold at three or more amino acid residues and capable of binding to two or more separate targets, comprising the steps of: (a) providing a first repertoire of polypeptides, each polypeptide comprising two or more reactive groups capable of covalent linkage to a molecular scaffold, and at least one loop which comprises a sequence of two or more amino acids subtended between two of said reactive groups; (b) providing a second repertoire of polypeptides as described in (a); (c) joining at least one loop of one or more members of the first repertoire to at least one loop of one or more members of the second repertoire to form at least one polypeptide comprising two loops, and (d) conjugating the composite polypeptide(s) to a molecular scaffold at at least three amino acid positions. |
| Inventors: | Winter, Gregory Paul (Cambridge, GB); Heinis, Christian (Bern, CH); Bernard, Elise (Cambridge, GB); Loakes, David (Cambridge, GB); Tite, John (Royston, GB); Vaysburd, Marina (Cambridge, GB); Teufel, Daniel Paul (Cambridge, GB); Riechmann, Lutz (Cambridge, GB) |
| Assignees: | Bicycle Therapeutics Limited (Cambridge, GB) |
| Claim: | 1. A method for providing a multispecific peptide ligand comprising a polypeptide covalently linked to a molecular scaffold at three or more amino acid residues and capable of binding to two or more separate targets, comprising the steps of: (a) providing a first phage displayed repertoire of polypeptides, each polypeptide comprising two or more reactive groups capable of covalent linkage to tris-(bromomethyl)benzene (TBMB), and at least one loop which comprises a sequence of two or more amino acids subtended between two of said reactive groups; (b) providing a second phage displayed repertoire of polypeptides as described in (a); wherein said first and second phage displayed repertoires are screened for binding to first and second targets to isolate one or more members for use in step (c); wherein said first and second phage displayed repertoires are screened for binding by conjugating said members of said first and second phage displayed repertoire to TBMB, and screening for binding of said first and second phage displayed repertoires against said first or second target; wherein the members of said first and second phage displayed repertoires are conjugated to said TBMB to form at least one loop; wherein said TBMB is present at less than 100 μM during conjugating to said first and second phage displayed repertoires; wherein said first and second phage displayed repertoires of polypeptides are encoded by a first and a second library of nucleic acid molecules; wherein the screening of said first and second phage displayed repertoires is performed using phage display; (c) joining at least one loop of one or more members of the phage encoded first repertoire to at least one loop of one or more members of the phage encoded second repertoire to form at least one polypeptide comprising two loops, and (d) conjugating the composite polypeptide(s) to a molecular scaffold at at least three amino acid positions, thereby forming the multispecific peptide ligand. |
| Claim: | 2. The method of claim 1 , wherein the members said first phage displayed repertoire are conjugated to said TBMB to form two or more loops, and wherein a single loop thereof is joined to at least one loop of the members of the second phage displayed repertoire. |
| Claim: | 3. The method of claim 1 , wherein step (c) results in the formation of a third repertoire of peptide ligands. |
| Claim: | 4. The method of claim 3 , wherein one of said first or second phage displayed repertoires is native. |
| Claim: | 5. The method of claim 1 , wherein polypeptide conjugates of said first and second phage displayed repertoires are treated with a protease. |
| Claim: | 6. The method of claim 5 , wherein said polypeptide conjugates of said first and second phage displayed repertoires are treated with a reducing agent and a protease. |
| Claim: | 7. The method of claim 1 , wherein the multispecific peptide ligand is dual specific. |
| Claim: | 8. The method of claim 3 , wherein binding to the first and second targets by members of said third repertoire can occur simultaneously. |
| Claim: | 9. The method of claim 3 , wherein binding to the first and second targets by members of said third repertoire cannot occur simultaneously. |
| Claim: | 10. The method of claim 9 , wherein members of said third repertoire are screened against said first target, and those that bind said first target are then screened against said second target. |
| Claim: | 11. The method of claim 10 , wherein after said first screening for binding to said first target, said third repertoire is amplified and then screened against said second target. |
| Current U.S. Class: | 506/9 |
| Patent References Cited: | WO 2009/098450 August 2009 |
| Other References: | Shrivastava et al. (Aug. 8, 2005) Protein Engineering Design and Selection vol. 18 pp. 417 to 424. cited by examiner Timmerman et al. (Apr. 5, 2005) ChemBioChem vol. 6 pp. 821 to 824. cited by examiner PCT International Search Report for PCT/EP2010/000689, dated Aug. 9, 2011. cited by applicant Heinis, et al., “Phage-encoded combinatorial chemical libraries based on bicyclic peptides”, Nature Chemical Biology, 5(7):502-07(2009). cited by applicant Cabras, et al., “HPLC-MS characterization of cyclo-statherin Q-37, a specific cyclization product of human salivary statherin generated by transglutaminase 2”, J. of Separation Science, 29(17):2600-08 (2006). cited by applicant |
| Assistant Examiner: | Boesen, Christian |
| Primary Examiner: | Calamita, Heather |
| Attorney, Agent or Firm: | Convergent Law Group LLP |
| رقم الانضمام: | edspgr.08685890 |
| قاعدة البيانات: | USPTO Patent Grants |
| الوصف غير متاح. |